Sonia Okuyama

671 total citations
19 papers, 437 citations indexed

About

Sonia Okuyama is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Sonia Okuyama has authored 19 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pediatrics, Perinatology and Child Health and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Sonia Okuyama's work include Cancer survivorship and care (6 papers), BRCA gene mutations in cancer (4 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Sonia Okuyama is often cited by papers focused on Cancer survivorship and care (6 papers), BRCA gene mutations in cancer (4 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). Sonia Okuyama collaborates with scholars based in United States, France and Hong Kong. Sonia Okuyama's co-authors include D. Ross Camidge, Xian Lu, Angela M. Davies, Scott A. Kono, Robert C. Doebele, Wilbur A. Franklin, Ana B. Oton, Anna E. Barón, Marileila Varella‐Garcia and Stacy M. Fischer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Sonia Okuyama

18 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sonia Okuyama United States 9 272 213 123 81 66 19 437
Deepa Wadhwa Canada 6 249 0.9× 229 1.1× 165 1.3× 84 1.0× 28 0.4× 10 566
Po‐Jung Su Taiwan 14 239 0.9× 83 0.4× 210 1.7× 79 1.0× 40 0.6× 47 534
C. Louzado Canada 7 250 0.9× 90 0.4× 96 0.8× 68 0.8× 50 0.8× 11 442
Danielle D. Durham United States 12 220 0.8× 106 0.5× 102 0.8× 34 0.4× 62 0.9× 33 419
Isra Levy Canada 13 171 0.6× 137 0.6× 102 0.8× 89 1.1× 87 1.3× 20 558
Richard Lee United States 8 328 1.2× 89 0.4× 66 0.5× 42 0.5× 57 0.9× 11 453
Reginald C. S. Ho United States 9 205 0.8× 187 0.9× 229 1.9× 26 0.3× 161 2.4× 19 620
Rebeca Franco United States 14 243 0.9× 69 0.3× 102 0.8× 39 0.5× 118 1.8× 39 580
Laëtitia Daubisse‐Marliac France 14 295 1.1× 104 0.5× 44 0.4× 102 1.3× 46 0.7× 35 543
Nicholas Zdenkowski Australia 15 294 1.1× 100 0.5× 192 1.6× 65 0.8× 166 2.5× 59 597

Countries citing papers authored by Sonia Okuyama

Since Specialization
Citations

This map shows the geographic impact of Sonia Okuyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonia Okuyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonia Okuyama more than expected).

Fields of papers citing papers by Sonia Okuyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonia Okuyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonia Okuyama. The network helps show where Sonia Okuyama may publish in the future.

Co-authorship network of co-authors of Sonia Okuyama

This figure shows the co-authorship network connecting the top 25 collaborators of Sonia Okuyama. A scholar is included among the top collaborators of Sonia Okuyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonia Okuyama. Sonia Okuyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Borrayo, Evelinn A., Elizabeth Juarez‐Colunga, Kristin Kilbourn, et al.. (2023). Stepped‐care to improve mental health outcomes among underserved patients with lung and head and neck cancer. Psycho-Oncology. 32(11). 1718–1726. 3 indexed citations
3.
Knerr, Sarah, Tia L. Kauffman, Kathleen F. Mittendorf, et al.. (2023). Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study. Cancer Medicine. 12(18). 19112–19125. 1 indexed citations
4.
Knerr, Sarah, Karen J. Wernli, Kathleen F. Mittendorf, et al.. (2023). Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system. Breast Cancer Research and Treatment. 201(3). 461–470. 1 indexed citations
5.
Knerr, Sarah, Kathleen F. Mittendorf, Heather Spencer Feigelson, et al.. (2022). Risk‐reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system. Cancer. 128(16). 3090–3098. 5 indexed citations
6.
Lindberg, Nangel M., Kathleen F. Mittendorf, Devan M. Duenas, et al.. (2022). Engaging Patient Advisory Committees to Inform a Genomic Cancer Risk Study: Lessons for Future Efforts. The Permanente Journal. 26(2). 28–39. 3 indexed citations
7.
Panse, Jens, Nicolas Daguindau, Sonia Okuyama, et al.. (2022). MDS-112 Normalization of Hematologic and Health-Related Quality of Life Markers in Patients With Paroxysmal Nocturnal Hemoglobinuria Treated With Pegcetacoplan and Baseline Hemoglobin at or Above 10 g/dL. Clinical Lymphoma Myeloma & Leukemia. 22. S305–S305. 1 indexed citations
8.
Mittendorf, Kathleen F., Chinedu Ukaegbu, Marian J. Gilmore, et al.. (2021). Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population. Familial Cancer. 21(2). 167–180. 9 indexed citations
9.
Panse, Jens, Nicolas Daguindau, Sonia Okuyama, et al.. (2021). Post Hoc Analysis of the Effect of Pegcetacoplan Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria and Baseline Hemoglobin Levels Greater Than 10 Grams per Deciliter. Blood. 138(Supplement 1). 2194–2194. 1 indexed citations
11.
Fischer, Stacy M., et al.. (2017). Apoyo con Cariño: Strategies to Promote Recruiting, Enrolling, and Retaining Latinos in a Cancer Clinical Trial. Journal of the National Comprehensive Cancer Network. 15(11). 1392–1399. 41 indexed citations
12.
Okuyama, Sonia, et al.. (2017). A Case of Fulminant Meningococcemia: It Is All in the Complement. SHILAP Revista de lepidopterología. 2017. 1–3. 8 indexed citations
13.
Main, Deborah S., et al.. (2015). Prevalence and Predictors of Distress in Posttreatment Adult Leukemia and Lymphoma Survivors. Journal of Psychosocial Oncology. 33(2). 124–141. 17 indexed citations
14.
Main, Deborah S., et al.. (2015). Understanding Distress in Posttreatment Adult Leukemia and Lymphoma Survivors: A Lifespan Perspective. Journal of Psychosocial Oncology. 33(2). 142–162. 16 indexed citations
15.
Okuyama, Sonia, et al.. (2014). Psychosocial telephone interventions for patients with cancer and survivors: a systematic review. Psycho-Oncology. 24(8). 857–870. 35 indexed citations
16.
Garrett, Kathleen, Sonia Okuyama, Zung Vu Tran, et al.. (2013). Bridging the transition from cancer patient to survivor: Pilot study results of the Cancer Survivor Telephone Education and Personal Support (C-STEPS) program. Patient Education and Counseling. 92(2). 266–272. 36 indexed citations
17.
Camidge, D. Ross, Scott A. Kono, Xian Lu, et al.. (2011). Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed. Journal of Thoracic Oncology. 6(4). 774–780. 195 indexed citations
18.
Lewis, Karl D., Sonia Okuyama, & René González. (2010). Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based review. PubMed. 5. 39–39. 10 indexed citations
19.
Okuyama, Sonia, et al.. (1984). Principia of cancer therapy VIII. Role of D-penicillamine in the prevention of radiation pneumonitis and fibrosis: an experimental demonstration.. PubMed. 31(1-4). 30–1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026